Skip to main content

The Role of Cardiac Magnetic Resonance in Selecting Patients with Left Ventricular Dysfunction Undergoing Surgical Ventricular Reconstruction

  • Chapter
  • First Online:
New Diagnostic, Therapeutic and Organizational Strategies for Acute Coronary Syndromes Patients

Part of the book series: Contributions to Statistics ((CONTRIB.STAT.))

  • 871 Accesses

Abstract

Surgical ventricular reconstruction (SVR) has gained wide acceptance over the past 10 years as a surgical treatment for ischemic heart failure. However, data from the largest randomized trial have questioned the real additional benefit of SVR in respect of coronary artery bypass grafting (CABG) alone, outlining the need to improve patient selection. To this aim, we investigated the role of cardiac magnetic resonance (CMR) in characterizing the extent of myocardial fibrosis and its prognostic value in patients affected by ischemic cardiomyopathy (ICM).

Twenty-five patients (mean age 68 ± 8 years) affected by ICM, a left ventricle ejection fraction (EF) < 40 %, and referred for CABG underwent late gadolinium enhancement (LGE)-CMR before and 6 months after surgery and were included in Group 1. Forty patients (mean age 65 ± 10 years) affected by ICM, a left ventricle EF < 40 %, and referred for CABG plus SVR underwent the same protocol and were included in Group 2. In Group 1, patients showed a high percentage of viable myocardium, a percentage of recoverable myocardium higher than 50 %, and a low percentage of hyperenhanced tissue, indicating a low degree of fibrosis. At 6 months, end-diastolic volume index (EDVI) decreased by 23 %, end-systolic volume index (ESVI) decreased by 38 %, and ejection fraction (EF) increased by 13 absolute points. Conversely, in Group 2, a lower percentage of viable tissue and a higher percentage of hyperenhanced tissue identified patients with more dilated ventricles and lower EF. At the multivariate analysis, only the percentage of scar tissue at the basal portion has been resulted to be significantly associated with an adverse outcome (P = 0.04, OR 1.26, 95 % CI 1.01–1.58) in Group 2.

In patients affected by ICM and LV dysfunction, the myocardial tissue characterization by LGE–CMR might be useful in predicting the postoperative adverse outcome after SVR.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gheorghiade, M., Sopko, G., De Luca, L., et al.: Navigating the crossroads of coronary artery disease and heart failure. Circulation 114, 1202–1213 (2006)

    Article  Google Scholar 

  2. Menicanti, L., Castelvecchio, S.: Left ventricular reconstruction concomitant to coronary artery bypass grafting: when and how? Curr. Opin. Cardiol. 26, 523–527 (2011)

    Article  Google Scholar 

  3. Menicanti, L., Castelvecchio, S., Ranucci, M., et al.: Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration. J. Thorac. Cardiovasc. Surg. 134, 433–441 (2007)

    Article  Google Scholar 

  4. Jones, R.H., Velazquez, E.J., Michler, R.E., STICH Hypothesis 2 Investigators, et al.: Coronary bypass surgery with or without surgical ventricular reconstruction. N. Engl. J. Med. 360, 1705–1717 (2009)

    Article  Google Scholar 

  5. Schuster, A., Morton, G., Chiribiri, A.: Imaging in the management of ischemic cardiomyopathy. J. Am. Coll. Cardiol. 59, 359–370 (2012)

    Article  Google Scholar 

  6. Allman, K.C., Shaw, L.J., Hachamovitch, R., Udelson, J.E.: Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J. Am. Coll. Cardiol. 39, 1151–1158 (2002)

    Article  Google Scholar 

  7. Bourque, J.M., Hasselblad, V., Velazquez, E.J., et al.: Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis. Am. Heart J. 146, 621–627 (2003)

    Article  Google Scholar 

  8. Bonow, R.O., Maurer, G., Lee, K.L., STICH Trial Investigators, et al.: Myocardial viability and survival in ischemic left ventricular dysfunction. N. Engl. J. Med. 364, 1617–25 (2011)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Serenella Castelvecchio .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Castelvecchio, S., Menicanti, L. (2013). The Role of Cardiac Magnetic Resonance in Selecting Patients with Left Ventricular Dysfunction Undergoing Surgical Ventricular Reconstruction. In: Grieco, N., Marzegalli, M., Paganoni, A. (eds) New Diagnostic, Therapeutic and Organizational Strategies for Acute Coronary Syndromes Patients. Contributions to Statistics. Springer, Milano. https://doi.org/10.1007/978-88-470-5379-3_8

Download citation

Publish with us

Policies and ethics